Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.

Curr Alzheimer Res

Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Published: September 2020

AI Article Synopsis

Article Abstract

Alzheimer's disease is the world's most common dementing illness. It is pathologically characterized by β-amyloid accumulation, extracellular senile plaques and intracellular neurofibrillary tangles formation, and neuronal necrosis and apoptosis. Neuroinflammation has been widely recognized as a crucial process that participates in AD pathogenesis. In this review, we briefly summarized the involvement of microglia in the neuroinflammatory process of Alzheimer's disease. Its roles in the AD onset and progression are also discussed. Numerous molecules, including interleukins, tumor necrosis factor alpha, chemokines, inflammasomes, participate in the complex process of AD-related neuroinflammation and they are selectively discussed in this review. In the end of this paper from an inflammation- related perspective, we discussed some potential therapeutic choices.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1567205016666190503151648DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
12
therapeutic choices
8
neuroinflammation alzheimer's
4
disease microglia
4
microglia molecular
4
molecular participants
4
participants therapeutic
4
choices alzheimer's
4
disease world's
4
world's common
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!